Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine dose comparison during hysteroscopy
ChiCTR2300068515Phase 4Not yet recruiting
- Sponsor
- Shaanxi Provincial People's Hospital
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nalbuphine in perioperative pain (3 arms), sponsored by Shaanxi Provincial People's Hospital. Primary endpoints: Intraoperative limb activity rate, Incidence of respiratory depression and 2 more. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on ChiCTR2300068515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068515.